| Latest Elite Pharmaceuticals News Headlines | | Date | Time | Source | | | 12/07/2005 | 6:30PM | PRNUS | Elite Pharmaceuticals To Present at The New York Society of Security Analysts 8th Annual Healthcare Industry Conference
NORTHVALE, N.J., Dec. 7 /PRNewswire-FirstCall/ -- Elite Pharmaceuticals, Inc. (AMEX:ELI) announced that Bernard Berk, Chairman and CEO, will present at the New York Society of Security Analysts (NYSSA) 9th Annual Healthcare Industry Conference Wednesday, December 14th at 11:20am EST.
The NYSSA 9th Annual Healthcare... More...>> |
| 11/15/2005 | 10:41AM | PRNUS | Elite Pharmaceuticals Reviews Business Developments and Projected Corporate Milestones - Company To Host an Investor Conference Call At 4:30 EST Today
NORTHVALE, N.J., Nov. 15 /PRNewswire-FirstCall/ -- Elite Pharmaceuticals, Inc. (AMEX:ELI) provided an update on recent achievements and projected timelines for both its pain management and controlled released drug delivery programs.
Pain Management
Elite... More...>> |
| 09/07/2005 | 11:59AM | PRNUS | Elite Pharmaceutical Announces Successful Completion of Bond Refinancing
NORTHVALE, N.J., Sept. 7 /PRNewswire-FirstCall/ -- Elite Pharmaceuticals, Inc. (AMEX:ELI) announced today that it has successfully completed a $4,155,000 bond financing through the New Jersey Economic Development Authority with the proceeds to be used to redeem previously issued tax-exempt bonds issued by the Authority... More...>> |
| 07/21/2005 | 10:28AM | PRNUS | Elite Pharmaceuticals to Present at The Banc of America Securities 2005 Specialty Pharmaceutics Conference Elite Pharmaceuticals to Present at The Banc of America
Securities 2005 Specialty Pharmaceutics Conference
NORTHVALE, N.J., July 21 /PRNewswire-FirstCall/ -- Elite Pharmaceuticals, Inc.
(AMEX:ELI) is pleased to announce that the Company has been invited to present
at Banc of America Securities 2005 Specialty Pharmaceuticals... More...>> |
| 06/28/2005 | 1:49PM | PRNUS | Elite Pharmaceuticals Announces Agreement for the Development of a Controlled Release Product Elite Pharmaceuticals Announces Agreement for the Development of
a Controlled Release Product
NORTHVALE, N.J., June 28 /PRNewswire/ -- Elite Pharmaceuticals, Inc.
(AMEX:ELI) announced that it has entered into a product development and license
agreement with Pliva, Inc. (East Hanover, NJ), a subsidiary of PLIVA d.d... More...>> |
| 06/22/2005 | 8:32AM | PRNUS | Elite Pharmaceuticals and IntelliPharmaCeutics Announce Agreement for the Development of a Controlled Release Product Elite Pharmaceuticals and IntelliPharmaCeutics Announce Agreement
for the Development of a Controlled Release Product
NORTHVALE, N.J., June 22 /PRNewswire-FirstCall/ -- Elite Pharmaceuticals, Inc.
(AMEX:ELI) and IntelliPharmaCeutics Corp. (Toronto, Canada), a privately held,
specialty pharmaceutical company, announced... More...>> |
| 06/22/2005 | 8:32AM | PRNUS | Elite Pharmaceuticals and IntelliPharmaCeutics Announce Agreement for the Development of a Controlled Release Product Elite Pharmaceuticals and IntelliPharmaCeutics Announce Agreement
for the Development of a Controlled Release Product
NORTHVALE, N.J., June 22 /PRNewswire-FirstCall/ -- Elite Pharmaceuticals, Inc.
(AMEX:ELI) and IntelliPharmaCeutics Corp. (Toronto, Canada), a privately held,
specialty pharmaceutical company, announced... More...>> |
| 06/22/2005 | 8:32AM | PRNUS | Elite Pharmaceuticals and IntelliPharmaCeutics Announce Agreement for the Development of a Controlled Release Product Elite Pharmaceuticals and IntelliPharmaCeutics Announce Agreement
for the Development of a Controlled Release Product
NORTHVALE, N.J., June 22 /PRNewswire-FirstCall/ -- Elite Pharmaceuticals, Inc.
(AMEX:ELI) and IntelliPharmaCeutics Corp. (Toronto, Canada), a privately held,
specialty pharmaceutical company, announced... More...>> |
| 06/22/2005 | 8:32AM | PRNUS | Elite Pharmaceuticals and IntelliPharmaCeutics Announce Agreement for the Development of a Controlled Release Product Elite Pharmaceuticals and IntelliPharmaCeutics Announce Agreement
for the Development of a Controlled Release Product
NORTHVALE, N.J., June 22 /PRNewswire-FirstCall/ -- Elite Pharmaceuticals, Inc.
(AMEX:ELI) and IntelliPharmaCeutics Corp. (Toronto, Canada), a privately held,
specialty pharmaceutical company, announced... More...>> |
| 06/22/2005 | 8:31AM | PRNUS | Elite Pharmaceuticals and IntelliPharmaCeutics Announce Agreement for the Development of a Controlled Release Product Elite Pharmaceuticals and IntelliPharmaCeutics Announce Agreement
for the Development of a Controlled Release Product
NORTHVALE, N.J., June 22 /PRNewswire-FirstCall/ -- Elite Pharmaceuticals, Inc.
(AMEX:ELI) and IntelliPharmaCeutics Corp. (Toronto, Canada), a privately held,
specialty pharmaceutical company, announced... More...>> |
| 06/22/2005 | 8:31AM | PRNUS | Elite Pharmaceuticals and IntelliPharmaCeutics Announce Agreement for the Development of a Controlled Release Product Elite Pharmaceuticals and IntelliPharmaCeutics Announce Agreement
for the Development of a Controlled Release Product
NORTHVALE, N.J., June 22 /PRNewswire-FirstCall/ -- Elite Pharmaceuticals, Inc.
(AMEX:ELI) and IntelliPharmaCeutics Corp. (Toronto, Canada), a privately held,
specialty pharmaceutical company, announced... More...>> |
| 06/22/2005 | 8:31AM | PRNUS | Elite Pharmaceuticals and IntelliPharmaCeutics Announce Agreement for the Development of a Controlled Release Product Elite Pharmaceuticals and IntelliPharmaCeutics Announce Agreement
for the Development of a Controlled Release Product
NORTHVALE, N.J., June 22 /PRNewswire-FirstCall/ -- Elite Pharmaceuticals, Inc.
(AMEX:ELI) and IntelliPharmaCeutics Corp. (Toronto, Canada), a privately held,
specialty pharmaceutical company, announced... More...>> |
| 06/22/2005 | 8:31AM | PRNUS | Elite Pharmaceuticals and IntelliPharmaCeutics Announce Agreement for the Development of a Controlled Release Product Elite Pharmaceuticals and IntelliPharmaCeutics Announce Agreement
for the Development of a Controlled Release Product
NORTHVALE, N.J., June 22 /PRNewswire-FirstCall/ -- Elite Pharmaceuticals, Inc.
(AMEX:ELI) and IntelliPharmaCeutics Corp. (Toronto, Canada), a privately held,
specialty pharmaceutical company, announced... More...>> |
| 06/22/2005 | 8:31AM | PRNUS | Elite Pharmaceuticals and IntelliPharmaCeutics Announce Agreement for the Development of a Controlled Release Product Elite Pharmaceuticals and IntelliPharmaCeutics Announce Agreement
for the Development of a Controlled Release Product
NORTHVALE, N.J., June 22 /PRNewswire-FirstCall/ -- Elite Pharmaceuticals, Inc.
(AMEX:ELI) and IntelliPharmaCeutics Corp. (Toronto, Canada), a privately held,
specialty pharmaceutical company, announced... More...>> |
| 06/22/2005 | 8:31AM | PRNUS | Elite Pharmaceuticals and IntelliPharmaCeutics Announce Agreement for the Development of a Controlled Release Product Elite Pharmaceuticals and IntelliPharmaCeutics Announce Agreement
for the Development of a Controlled Release Product
NORTHVALE, N.J., June 22 /PRNewswire-FirstCall/ -- Elite Pharmaceuticals, Inc.
(AMEX:ELI) and IntelliPharmaCeutics Corp. (Toronto, Canada), a privately held,
specialty pharmaceutical company, announced... More...>> |
| 06/22/2005 | 8:31AM | PRNUS | Elite Pharmaceuticals and IntelliPharmaCeutics Announce Agreement for the Development of a Controlled Release Product Elite Pharmaceuticals and IntelliPharmaCeutics Announce Agreement
for the Development of a Controlled Release Product
NORTHVALE, N.J., June 22 /PRNewswire-FirstCall/ -- Elite Pharmaceuticals, Inc.
(AMEX:ELI) and IntelliPharmaCeutics Corp. (Toronto, Canada), a privately held,
specialty pharmaceutical company, announced... More...>> |
| 06/22/2005 | 8:31AM | PRNUS | Elite Pharmaceuticals and IntelliPharmaCeutics Announce Agreement for the Development of a Controlled Release Product Elite Pharmaceuticals and IntelliPharmaCeutics Announce Agreement
for the Development of a Controlled Release Product
NORTHVALE, N.J., June 22 /PRNewswire-FirstCall/ -- Elite Pharmaceuticals, Inc.
(AMEX:ELI) and IntelliPharmaCeutics Corp. (Toronto, Canada), a privately held,
specialty pharmaceutical company, announced... More...>> |
| 06/22/2005 | 8:31AM | PRNUS | Elite Pharmaceuticals and IntelliPharmaCeutics Announce Agreement for the Development of a Controlled Release Product Elite Pharmaceuticals and IntelliPharmaCeutics Announce Agreement
for the Development of a Controlled Release Product
NORTHVALE, N.J., June 22 /PRNewswire-FirstCall/ -- Elite Pharmaceuticals, Inc.
(AMEX:ELI) and IntelliPharmaCeutics Corp. (Toronto, Canada), a privately held,
specialty pharmaceutical company, announced... More...>> |
| 06/22/2005 | 8:31AM | PRNUS | Elite Pharmaceuticals and IntelliPharmaCeutics Announce Agreement for the Development of a Controlled Release Product Elite Pharmaceuticals and IntelliPharmaCeutics Announce Agreement
for the Development of a Controlled Release Product
NORTHVALE, N.J., June 22 /PRNewswire-FirstCall/ -- Elite Pharmaceuticals, Inc.
(AMEX:ELI) and IntelliPharmaCeutics Corp. (Toronto, Canada), a privately held,
specialty pharmaceutical company, announced... More...>> |
| 06/22/2005 | 8:31AM | PRNUS | Elite Pharmaceuticals and IntelliPharmaCeutics Announce Agreement for the Development of a Controlled Release Product Elite Pharmaceuticals and IntelliPharmaCeutics Announce Agreement
for the Development of a Controlled Release Product
NORTHVALE, N.J., June 22 /PRNewswire-FirstCall/ -- Elite Pharmaceuticals, Inc.
(AMEX:ELI) and IntelliPharmaCeutics Corp. (Toronto, Canada), a privately held,
specialty pharmaceutical company, announced... More...>> |
|